ISA Timeline and Comment Process

Comment

Nice

Nice

Thank you for the…

Thank you for the opportunity to comment on the new version of Interoperability Standards Advisory (ISA) 2024. The attached comments are provided on behalf of Washington State Department of Health.

ISA 2024 Comments WA DOH.docx

CAQH CORE 2025 ISA Updates

CAQH CORE reviewed the ISA and indicated recommended edits in the attached comment letter. 

CORE Submission_2025 ISA Updates.pdf

NEW ISA platform

The FEHRM has reviewed the ISA website and submitted the attached file with our comments.

ASI_Comments_08062024-.docx

Integration of Continuous Glucose Monitor Data into the EHR

A consensus group of 130 stakeholders (organized by Diabetes Technology Society) from academia, government, and industry developed iCoDE with data standards and workflow processes for integrating the wearable device Continuous Glucose Monitors into the EHR. The iCoDE standard contained 54 recommendations when it was completed in November 2022.  Many of its terms for expressing results of CGM testing are worthy of adoption by the (next) USCDI 5.  The link to the iCoDE standard is here: <https://www.diabetestechnology.org/icode/>

DirectTrust ISA Updates - 2023

Updates to links for permanence. Updates to adoption levels. Inclusion of Context IG now that it is in use in the Notifications Standard.  ANSI Naming added to ANSI approved standards.

ISA Updates 2023 0 DirectTrust.xlsx

CORE Response to the 2024 ISA Open Comment Period

Thank you for the opportunity to provide substantive recommendations that promote consistency and update the content of the ISA. Comprehensive responses from CORE can be found at this link: CORE Submission for the 2024 ISA Open Comment Period. This link has also been posted to relevant pages throughout the ISA, referencing page numbers where edits can be found.

Please note, on page 2 of the linked letter, CORE has made several recommendations that ensure consistency of Operating Rule nomenclature across all pages of the ISA.

Please do not hesitate to contact us with questions.